Kinase Profiling Inhibitor Database

This is a searchable database of specificities of 55684 commonly used signal transduction inhibitors. These results have been provided by the International Centre for Kinase profiling within the MRC Protein Phosphorylation Unit at the University of Dundee.

We strongly recommend undertaking kinase profiling of any kinase inhibitor to be used in a biological experiment. It is essential to have a good feel for the specificity of the kinase inhibitor you are working with in order to be able to properly interpret your data.

If you have additional kinase inhibitors that you would like the International Centre for Kinase profiling team to profile for you please contact us here for further details.

If you have any feedback or suggestions on how to improve this resource we welcome your input. Pass on your ideas to us here.

Inhibitor Brutto MW Action Reference Screen Conc % Activity Remaining
MRT199665   C28H31N5O2.ClH 506.04 MARK Clark K. (2012) Proc Natl Acad Sci USA 109(42) 16986-91

WO2009152027
0.10 96
NIK-Novartis-T1-7   C18H14N6OS 362.41 NIK
US20120214762
1.00 106
OSU-03012 C26H19F3N4O 460.45 PDK1 Zhu J. (2004) Cancer Res. 64(12) 4309-18


10.00 105
OSU-03012 C26H19F3N4O 460.45 PDK1 Zhu J. (2004) Cancer Res. 64(12) 4309-18


1.00 119
OTSSP167 C25H28Cl2N4O2 487.42 MELK

0.10 110
OTSSP167 C25H28Cl2N4O2 487.42 MELK

1.00 111
Parthenolide C15H20O3 248.32 IKKβ Kwok B.H. (2001) Chem. Biol. 8 759-766


1.00 112
Parthenolide C15H20O3 248.32 IKKβ Kwok B.H. (2001) Chem. Biol. 8 759-766


5.00 100
PD 0325901   C16H14F3IN2O4 482.19 MEK1 Bain J. (2007) Biochem J. 408 297–315.
Barrett SD. (2008) Bioorg. Med. Chem. Lett. 18 6501-6504.
WO2002006213
1.00 102
PF3644022   C21H18N4OS 374.46 MAPKAPK2 Mourey (2010) J.Pharmacol.Exp.Ther. 333 797


1.00 108